antisense technology, page-20

Nice one Itsa , big pharmas' certainly are keen to snap up opportunities with orphan drug status. Roche loves the technology, is working closely with Isis and has just shown a massive interest in the acromegaly market. It's been a bad month or so but I'm becoming less concerned about where we are at now and more focused on the incredible potential that this little bio is close to tapping. Nothing has changed it's just each day we are getting closer and if we get preliminary results released then that day is closer than everyone thinks.